Companies / harbin-pharmaceutical-600664

Harbin Pharmaceutical (600664)

ChinaIndustrial & Manufacturing

Overview

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese med

Employees10039
Market Cap$8.0B
Revenue$16.0B
Listed OnShanghai Stock Exchange
Ticker600664
CEOMr. Chuanyou Lu
HeadquartersHarbin

Website

https://www.hayao.com